July 2019 – Page 2 – Policy & Medicine

Three Pharma Companies Sue HHS, Judge Rules in Their Favor

SCOTUS Rules Judge Should Decide Merck Labeling Case

New FDA Draft Guidance on Opioid Benefit-Risk Assessment Includes Comparative Effectiveness Prong

Insys $225 Million Settlement and Corporate Integrity Agreement

Idaho Prescription Monitoring Program Monthly Manufacturer Reports for Controlled Substances Due Soon

Update: Econometrica and Open Payments Oversight

Senators Grassley and Wyden Expand Their Opioid Investigation to Tax-Exempt Organizations

Study Shows that Patients’ Out-of-Pocket Costs for Neurology Drugs Have Risen Dramatically In Last 12 Years

FDA Issues Advertising Warning Letter to Vivus

HHS OIG Report: Using Health IT for Care Coordination